Sentil Tab. 5mg

Ingredient

Clobazam

Content

5mg

Indication

1) Treatment of anxiety, tension
2) Treatment of anxiety, tension in mental retardation, autonomic dysfunction, sleep disorder, organic mental disorder
3) Adjunctive treatment of seizures when antiepileptic drug monotherapy is ineffective at controlling seizures

Solian Tab. 100mg

Ingredient

Amisulpride

Content

100mg

Indication

Treatment of schizophrenia

Solian Tab. 200mg

Ingredient

Amisulpride

Content

200mg

Indication

Treatment of schizophrenia

Solian Tab. 400mg

Ingredient

Amisulpride

Content

400mg

Indication

Treatment of schizophrenia

Stilnox CR Tab. 12.5mg

Ingredient

Zolpidem Tartrate

Content

12.5mg

Indication

Short-term treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance.

Stilnox CR Tab. 6.25mg

Ingredient

Zolpidem Tartrate

Content

6.25mg

Indication

Short-term treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance.

Stilnox Tab. 10mg

Ingredient

Zolpidem Tartrate

Content

10mg

Indication

Short-term treatment of insomnia in adults

Strensiq

Ingredient

Asfotase-alfa

Content

18 mg/0.45 mL, 28 mg/0.7 mL, 40 mg/mL, or 80 mg/0.8 mL solution in single-dose vials

Indication

Long-term enzyme replacement therapy in patients with pediatric-onset hypophosphatasia to treat the bone manifestations of the disease. Pediatric includes perinatal/infantile (0-6 months of age at the time of onset) and juvenile (6 months to 18 years of age at the time of onset).

Suglat^®Tablet 50mg

Ingredient

Ipragliflozin L-proline (In-house spec.) 64.3mg (50 mg as Ipragliflozin)

Content

Light purple, round, film-coated tablet

Indication

This drug is administered as an adjunct to diet and exercise to improve the glucose control of patients with type 2 diabetes.
– Monotherapy
– Combination therapy